SG10201606990TA - Methods for reducing levels of protein-contaminant complexes and aggregates in protein preparations by treatment with electropositive organic additives - Google Patents

Methods for reducing levels of protein-contaminant complexes and aggregates in protein preparations by treatment with electropositive organic additives

Info

Publication number
SG10201606990TA
SG10201606990TA SG10201606990TA SG10201606990TA SG10201606990TA SG 10201606990T A SG10201606990T A SG 10201606990TA SG 10201606990T A SG10201606990T A SG 10201606990TA SG 10201606990T A SG10201606990T A SG 10201606990TA SG 10201606990T A SG10201606990T A SG 10201606990TA
Authority
SG
Singapore
Prior art keywords
protein
aggregates
treatment
methods
organic additives
Prior art date
Application number
SG10201606990TA
Other languages
English (en)
Inventor
Peter Gagnon
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of SG10201606990TA publication Critical patent/SG10201606990TA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
SG10201606990TA 2012-05-31 2013-02-06 Methods for reducing levels of protein-contaminant complexes and aggregates in protein preparations by treatment with electropositive organic additives SG10201606990TA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261653752P 2012-05-31 2012-05-31

Publications (1)

Publication Number Publication Date
SG10201606990TA true SG10201606990TA (en) 2016-10-28

Family

ID=49673721

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201606990TA SG10201606990TA (en) 2012-05-31 2013-02-06 Methods for reducing levels of protein-contaminant complexes and aggregates in protein preparations by treatment with electropositive organic additives
SG11201407812SA SG11201407812SA (en) 2012-05-31 2013-02-06 Methods for reducing levels of protein-contaminant complexes and aggregates in protein preparations by treatment with electropositive organic additives

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201407812SA SG11201407812SA (en) 2012-05-31 2013-02-06 Methods for reducing levels of protein-contaminant complexes and aggregates in protein preparations by treatment with electropositive organic additives

Country Status (8)

Country Link
US (1) US10246506B2 (ja)
EP (1) EP2855502B1 (ja)
JP (2) JP2015519361A (ja)
KR (1) KR102067445B1 (ja)
CN (1) CN104507953B (ja)
IN (1) IN2014DN09948A (ja)
SG (2) SG10201606990TA (ja)
WO (1) WO2013180650A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150115745A (ko) * 2013-02-06 2015-10-14 에이전시 포 사이언스, 테크놀로지 앤드 리서치 단백질 제제로부터 응집체 함량을 감소시키는 방법
US10112971B2 (en) * 2013-02-26 2018-10-30 Agency For Science, Technology And Research Protein purification in the presence of nonionic organic polymers and electropositive surfaces
KR20150122650A (ko) 2013-02-28 2015-11-02 에이전시 포 사이언스, 테크놀로지 앤드 리서치 상승된 전도도에서 비이온성 유기 폴리머들의 존재에서의 단백질 정제
EP3116892A4 (en) * 2014-02-27 2017-11-22 Agency For Science, Technology And Research Methods for reducing aggregate content of protein preparations by treatment with aryl anions
KR20160118369A (ko) 2014-02-27 2016-10-11 에이전시 포 사이언스, 테크놀로지 앤드 리서치 항체 정제 프로세스
US10478498B2 (en) 2014-06-20 2019-11-19 Reform Biologics, Llc Excipient compounds for biopolymer formulations
WO2015196091A1 (en) 2014-06-20 2015-12-23 Reform Biologics, Llc Viscosity-reducing excipient compounds for protein formulations
CN109311937A (zh) * 2016-06-15 2019-02-05 新加坡科技研究局 增强用于纯化蛋白质的色谱法的性能的方法
KR20190027878A (ko) 2016-07-13 2019-03-15 리폼 바이오로직스, 엘엘씨 치료 단백질 제제용 안정화 부형제
DE102016010601B4 (de) 2016-09-01 2018-11-08 Sartorius Stedim Biotech Gmbh Verfahren zur Aufreinigung von Viren oder virusähnlichen Partikeln unter Verwendung einer vernetzten Cellulosehydrat-Membran
WO2019036619A1 (en) * 2017-08-18 2019-02-21 Reform Biologics, Llc STABILIZING EXCIPIENTS FOR FORMULATIONS OF THERAPEUTIC PROTEIN
CN113493570B (zh) * 2020-04-01 2022-11-01 中国科学院理化技术研究所 一种采用尿囊素降低明胶中内毒素的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
AU597924B2 (en) * 1985-12-11 1990-06-14 Natinco Nv Solubilization of protein aggregates
AU683698B2 (en) * 1993-10-06 1997-11-20 Amgen, Inc. Stable protein: phospholipid compositions and methods
US5691132A (en) 1994-11-14 1997-11-25 Cerus Corporation Method for inactivating pathogens in red cell compositions using quinacrine mustard
SE9500778D0 (sv) * 1995-03-03 1995-03-03 Pharmacia Ab Process for producing a protein
SE0201257D0 (sv) * 2002-04-25 2002-04-25 Medical Invest In Sweden Ab Improved Separation
CN1286453C (zh) * 2003-07-25 2006-11-29 复旦大学 一种稳定蛋白药物的方法及其在微球制备中的应用
ZA200904482B (en) 2007-01-22 2010-09-29 Genentech Inc Polyelectrolyte precipitation and purification of antibodies
WO2009046840A1 (en) 2007-10-12 2009-04-16 Merck Patent Gmbh Method and agent for refolding proteins
CA2726823A1 (en) 2008-06-03 2009-12-10 Patrys Limited Process for purification of antibodies
EP2241886A1 (en) * 2009-04-15 2010-10-20 Beckman Coulter Biomedical Limited Homogeneous agglutination immunoassay method and kit for such method
US9193760B2 (en) * 2010-09-20 2015-11-24 Bio-Rad Laboratories, Inc. Dissociation of product-complexed contaminants in chromatography
JP6200949B2 (ja) * 2012-05-31 2017-09-20 エイジェンシー フォー サイエンス，テクノロジー アンド リサーチ 固相ウレイドに対する生物学的標的物の選択的結合
JP6268167B2 (ja) * 2012-05-31 2018-01-24 エイジェンシー フォー サイエンス，テクノロジー アンド リサーチ タンパク質製剤中の凝集物含量を低減するために混合型多官能表面を使用する方法
WO2013180647A1 (en) * 2012-05-31 2013-12-05 Agency For Science, Technology And Research Chromatographic purification of immunoglobulin g preparations with particles having multimodal functionalities

Also Published As

Publication number Publication date
IN2014DN09948A (ja) 2015-08-14
EP2855502A1 (en) 2015-04-08
CN104507953A (zh) 2015-04-08
JP2015519361A (ja) 2015-07-09
KR102067445B1 (ko) 2020-01-17
KR20150028231A (ko) 2015-03-13
EP2855502A4 (en) 2016-02-17
SG11201407812SA (en) 2014-12-30
JP6491277B2 (ja) 2019-03-27
US10246506B2 (en) 2019-04-02
JP2017222699A (ja) 2017-12-21
WO2013180650A1 (en) 2013-12-05
US20150148526A1 (en) 2015-05-28
CN104507953B (zh) 2018-05-18
EP2855502B1 (en) 2019-06-26

Similar Documents

Publication Publication Date Title
SG10201606990TA (en) Methods for reducing levels of protein-contaminant complexes and aggregates in protein preparations by treatment with electropositive organic additives
LT3049056T (lt) Priešgrybelinė vietinė kompozicija ir gydymo būdai
SG11201505460WA (en) Methods for reducing aggregate levels in protein preparations by treatment with thio-heterocyclic cations
EP2863920A4 (en) METHOD AND COMPOSITIONS FOR TREATING DISEASES INVOLVING PROTEINS OF THE BCL-2 FAMILY WITH CHINOLINE DERIVATIVES
HK1201543A1 (en) Method for treating clay and clay-bearing aggregates and compositions therefor
EP3049536A4 (en) Methods and compositions relating to cancer therapy with dna damaging agents
DK3292875T3 (en) Compositions and methods for treating diseases
HK1224184A1 (zh) 用於治療炎性疾病的化合物、藥物組合物和方法
EP2855503A4 (en) METHOD OF USE OF MIXED MULTIFUNCTIONAL SURFACES TO REDUCE THE AGGREGATE CONTENT IN PROTEIN PREPARATIONS
EP3003290A4 (en) Compositions and methods for induced tissue regeneration in mammalian species
SG10201710538XA (en) Compositions and methods for treating skin
EP2968374A4 (en) METHODS AND COMPOSITIONS FOR IMPROVING OXYGEN RATE IN FABRICS
EP2922544A4 (en) METHOD AND COMPOSITIONS FOR TREATING ILLNESSES INVOLVED IN PROTEINS OF THE BCL-2 FAMILY USING ISOCHINOLINE AND CHINOLINE DERIVATIVES
EP3010504A4 (en) Methods and compositions to treat cancer
EP2683386A4 (en) COMPOUNDS AND APPLICATION METHODS IN AN ABLATION RADIO THERAPY
EP2956469A4 (en) METHODS AND COMPOSITIONS FOR CONCENTRATING PROTEINS
EP2928460A4 (en) METHODS FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY SKIN DISEASES
PT2941233T (pt) Composições e métodos para tratar linfoma cutâneo de células t
GB2501806B (en) Improvements in Treatment of Exhaust Emissions
GB2558442B (en) Antibodies for use in treating conditions related to specific PCSK9 variants and associated diagnostic methods
GB201306744D0 (en) Improvements in and relating to gate assemblies
AU2013904530A0 (en) Methods and apparatuses for improving peripheral activity in computing devices